Why Biotech Just Had Its Best Week in Years—And Why This Rally Could Be Different

Related Articles

Intel Just Had Its Best Day in Years—And Apple Might Be the Reason Why

11 months ago

What Catalyzed Datadog's Explosive Rally This Week

6 months ago

Why Did Bitcoin Just Have Its Worst Q1 in Eight Years

8 months ago

The AI Memory Gold Rush: Why This Chip Shortage Is Different—And How to Profit From It

12 months ago

Category

You may also like

Stock News•2 weeks ago

Biotech stocks are surging. How investors can play the new drug innovation boom

Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector, with analysts favoring select ETFs and stocks to play the innovation boom.

IBB

Share

News•2 months ago

Health Care's Next Act: Tailwinds Emerging Across R&D Cycle

Pharmaceuticals are rebounding as U.S. drug pricing clarity emerges, shifting focus to patent expirations and innovation-driven differentiation. Companies like JNJ and AZN, with diversified portfolios...

Share

Stock News•4 months ago

Why This Pharmaceutical Stock Jumped Close to 100% This Week

Shares of a pharmaceutical stock surged nearly 100% this week after agreeing to be acquired by a larger sector firm.

CRNX

Share